The Potassium Acetate Injection, cataloged under National Stock Number 6505-01-202-7998, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Lyphomed Inc Div of Fujisawa Usa Inc. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 6 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 10 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-202-7998 |
| Primary Part Number | NDC00469-7600-40 |
| Item Name | Potassium Acetate Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Lyphomed Inc Div of Fujisawa Usa Inc |
| Status | CANCELLED |
| Primary Container Type | VIAL, SINGLE DOSE |
| Active Medicament Medicinal Strength | 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Total Primary Container Quantity | 25 |
| Primary Container Content Quantity | 20.000 MILLILITERS |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00469-7600-40 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| NDC00517-2053-25 | Cardinal Health 100, Inc. (USA) |
| NDC00517-2053-25 | Cardinal Health 100, Inc Dba Bindley Western Tennessee Div (USA) |
| I-093 | Defense Medical Standardization Board (USA) |
| NDC00517-2053-25 | Luitpold Pharmaceuticals Inc Dba Osteohealth Company Div Osteohealth Company (USA) |
| 76-20 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
NSN 6505-01-202-7998 is a Potassium Acetate Injection, manufactured by Lyphomed Inc Div of Fujisawa Usa Inc, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-01-202-7998 has 6 cross-referenced part numbers: NDC00469-7600-40 (Lyphomed Inc Div of Fujisawa Usa Inc), NDC00517-2053-25 (Cardinal Health 100, Inc.), NDC00517-2053-25 (Cardinal Health 100, Inc Dba Bindley Western Tennessee Div), I-093 (Defense Medical Standardization Board), NDC00517-2053-25 (Luitpold Pharmaceuticals Inc Dba Osteohealth Company Div Osteohealth Company) and 1 more.
There are 10 known substitutes for 6505-01-202-7998: 3110-00-194-3955, 5960-00-981-2004, 5360-01-138-5117 and 7 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00469-7600-40: Primary Container Type: VIAL, SINGLE DOSE; Active Medicament Medicinal Strength: 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Total Primary Container Quantity: 25. 6 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-01-202-7998 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.